Novel human in vitro system for evaluating antimycobacterial vaccines

Infection and Immunity

Volumn 72, Issue 11, 2004, Pages 6401-6407

  Kampmann, Beate ^b,c,d   Tena, Gwen N ^a   Mzazi, Shumikazi ^a   Eley, Brian ^a   Young, Douglas B ^b   Levin, Michael ^b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b St Mary's Campus ^*  (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d St Mary s Campus   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; BCG VACCINE; GAMMA INTERFERON; TUBERCULIN; VACCINE;

ARTICLE; BCG VACCINATION; CYTOKINE PRODUCTION; DRUG SCREENING; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IN VITRO STUDY; INFANT; MALE; MYCOBACTERIUM BOVIS; NORMAL HUMAN; PRIORITY JOURNAL; REPORTER GENE; SOUTH AFRICA;

BCG VACCINE; BLOOD; CLINICAL TRIALS; GENES, REPORTER; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON TYPE II; LUCIFERASES; MYCOBACTERIUM BOVIS; RESEARCH DESIGN; SOUTH AFRICA; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINATION;

EID: 7244236723     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.11.6401-6407.2004     Document Type: Article

References (37)

1. al-Kassimi, F. A., M. S. al-Hajjaj, I. O. al-Orainey, E. A. Bamgboye. 1995. Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction? Am. J. Respir. Crit. Care Med. 152:1575-1578.
2. American Thoracic Society. 1981. The tuberculin skin test. Am. Rev. Respir. Dis. 124:356-363.
3. Beck, J. S., S. M. Morley, and J. H. Gibbs. 1986. The cellular responses of tuberculosis and leprosy patients and of healthy controls in skin tests to new tuberculin and leprosin. Clin. Exp. Immunol. 64:484-494.
4. Black, G. F., R. E. Weir, S. Floyd, L. Bliss, D. K. Warndorff, A. C. Crampin, B. Ngwira, L. Sichali, B. Nazareth, J. M. Blackwell, K. Branson, S. D. Chaguluka, L. Donovan, E. Jarman, E. King, P. E. Fine, and H. M. Dockrell. 2002. BCG-induced increase in interferon-gamma response to mycobacteria antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359:1393-1401.
5. Casanova, J. L., and L. Abel. 2002. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20:581-620.
6. Cheon, S. H., B. Kampmann, A. G. Hise, M. Phillips, H.-Y. Song, K. Landen, Q. Li, R. Larkin, J. J. Ellner, R. F. Silver, D. F. Hoft, and R. S. Wallis. 2002. Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis. Clin. Diagn. Lab. Immunol. 9:901-907.
7. a.City of Cape Town. City of Cape Town TB Control Programme Report 1997-2002. [Online.] www.who.int/gtb/TBHIV/Durban_feb03/mon/ mon6_naidoo_wcape_sa.ppt.
8. Colditz, G. A., C. S. Berkey, F. Mosteller, M. Brewer, M. E. Wilson, E. Burdick. and H. V. Fineberg. 1995. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: metaanalyses of the published literature. Pediatrics 96:29-35.
9. Ewer, K., J. Deeks, L. Alvarez, G. Bryant, S. Waller, P. Andersen, P. Monk, and A. Lalvani. 2003. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school outbreak. Lancet 361:1168-1173.
10. Fine, P. E. M. 1995. Variations in protection by BCG: implications of and for protective immunity. Lancet 346:1339-1345.
11. Fine, P. E. M., J. A. C. Sterne, J. M. Ponninghaus, and R. J. Rees 1994. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344:1245-1249.
12. Goriely, S., B. Vincart, P. Stordeur, F. Vekemans, F. Willems, M. Goldman, and D. de Wit. 2001. Deficient IL-12 (p35) gene expression by dendritic cells derived from neonatal monocytes. J. Immunol. 166:2141-2146.
13. Hart, P. D. A., and I. Sutherland. 1977. BCG and vole bacillus in the prevention of tuberculosis in adolescence and early adult life: final report to the Medical Research Council. Br. Med. J. 2:293-295.
14. Hickey, M. J., T. M. Arain, R. M. Shawar, D. J. Humble, M. H. Langhorne, J. N. Morgenroth, and C. K. Stover. 1996. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob. Agents Chemother. 40:400-407.
15. Hoft, D. F., R. M. Brown, and S. T. Rodman. 1997. Bacille Calmette-Guerin vaccination enhances human γ/δ T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J. Immunol. 161:1045-1054.
16. Hoft, D. F, S. Worku, B. Kampmann, C. Whalen, J. J. Ellner, C. S. Hirsch, R. B. Brown, R. Larkin, Q. Li, H. Yun, and R. F. Silver. 2002. Human BCG vaccination induces immune memory with enhanced inhibitory activity against intracellular mycobacteria. J. Infect. Dis. 186:1448-1457.
17. Hussey, G. D., M. L. Watkins, S. Gottschalk, E. J. Hughes, K. Iloni, M. Kibel, and S. R. Ress. 2002. Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology 105:314-324.
18. Jouanguy E., F. Altare, S. Lamhamedi, P. Revy, J. F. Emile, M. Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, and J. L. Casanova. 1996. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335:1956-1961.
19. Kampmann, B., P. O. Gaora, V. A. Snewin, M. P. Gares, D. B. Young, and M. Levin. 2000. Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. J. Infect. Dis. 182:895-901.
20. Karalliedde, S., L. P. Katugaha, and C. G. Uragoda. 1987. Tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle 68:33-38.
21. Lalvani, A., R. Brookes, R. J. Wilkinson, A. S. Malin, A. A. Pathan, P. Andersen, H. Dockrell, G. Pasvol, and A. V. Hill. 1998. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 5:270-275.
22. Malhotra, I., P. Mungani, A. Wamachi, J. Kioko, J. H. Ouma, J. W. Kazura, and C. L. King. 1999. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J. Immunol. 162:6843-6848.
23. Marchant, A., T. Goettghebuer, M. O. Ota, I. Wolfe, S. J. Ceesay, D. De Groote, et al. 1999. Newborns develop a Th1-type immune response to Mycobacterium bovis Bacillus Calmette-Guerin vaccination. J. Immunol. 163:2249-2255.
24. McMurray, D. N. 2003. Recent progress in the development and testing of vaccines against human tuberculosis. Int. J. Parasitol. 33:547-554.
25. Medaglini, D., and A. Hoeveler. 2003. The European research effort for HIV/AIDS, malaria and tuberculosis. Vaccine 21(Suppl. 2):S116-S120.
26. Miles, E. A., J. A. Warner, A. C. Lane, A. C. Jones, B. M. Colwell, and J. O. Warner. 1994. Altered T lymphocyte phenotype at birth in babies born to atopic parents. Pediatr. Allergy Immunol. 5:202-208.
27. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 26:1941-1949.
28. Odujinrin, O. M., and D. A. Ogumekan. 1992. Assessment of post-vaccination tuberculin sensitivity in Lagos-Nigeria. Eur. J. Epidemiol. 8:128-131.
29. Ota, M. O. C., J. Vekemans, S. E. Schlegel-Haueter, K. Fielding, M. Sanneh, M. Kidd, et al. 2002. Influence of Mycobacterium bovis Bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J. Immunol. 168:919-925.
30. Ravn, P., H. Boesen, B. K. Pedersen, and P. Andersen. 1997. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J. Immunol. 158:1949-1955.
31. Santiago, E. M., E. Lawson, K. Gillenwater, S. Kalangi, A. G. Lescano, G. Du Quella, K. Cummings, L. Cabrera, C. Torres, and R. H. Gilman. 2003. A prospective study of bacillus Calmette-Guerin scar formation and tuberculin skin test reactivity in infants in Lima, Peru. Pediatrics 112:e298. [Online.] htpp://pediatrics.aapublications.org/cgi/content/full/112/4/e298.
32. Smith, S., R. F. Jacobs, and C. B. Wilson. 1997. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J. Pediatr. 131:16-26.
33. Snewin, V. A., M.-P. Gares, P. Ó. Gaora, Z. Hasan, I. Brown, and D. B. Young. 1999. Assessment of immunity to mycobacterial infection using luciferase reporter constructs. Infect. Immun. 67:4586-4593.
34. Tena, G. B., D. B. Young, B. Eley, H. Henderson, M. P. Nicol, M. Levin, and B. Kampmann. 2003. Failure to control growth of mycobacteria in blood from children infected with HIV and its relationship to T cell function. J. Infect. Dis. 187:1544-1551.
35. Wang, J., and Z. Xing. 2002. Tuberculosis vaccines: the past, present and future. Expert Rev. Vaccines 1:341-354.
36. Youmans, G. P. 1975. Relationship between delayed hypersensitivity and immunity in tuberculosis. Am. Rev. Respir. Dis. 111:109.
37. Young, D. 2003. Ten years of research progress and what's to come. Tuberculosis 83:77-78.